Cancer Neutron Capture Therapy

ISBN 13: 9781475795691

Cancer Neutron Capture Therapy

0 avg rating
( 0 ratings by Goodreads )
 
9781475795691: Cancer Neutron Capture Therapy
View all copies of this ISBN edition:
 
 

There are many human cancers which actively synthesize specific characteristic proteins such as melanomas, thyroid cancer and squamous cell carcinoma. Many cancer researchers have of course tried to utilize this specific activity as a key for the selective treatment of cancers. In the past for example, the molecular hybrid compound of DOPA, a substrate of melanin, and nitrogen mustard N-oxide hydrochloride, a ctyotoxic anti-tumor drug, was synthesized as Melphalan and used to treat malignant melanoma. A major problem arose though in that it was soon found to be highly suppressive toward bone marrow and quite toxic while not being remarkably effective. Thus, malignant melanoma could not be cured by it. Such failure led us to develop a novel bimodal therapeutic system which includes the use of non-toxic potentially cytocidal chemicals which selectively accumulate within the cancer cells and which are converted by a controllable modality into an actively cytocidal element in situ. We can now non-surgically cure malignant melanoma and glioblastoma with our selective cancer treatment, neutron capture therapy (NCT); as can be found in this volume. Included are 124 papers on the latest breaking developments discussed at the Sixth International Symposium on NCT for Cancer held in Kobe during the late autumn of 1994.

"synopsis" may belong to another edition of this title.

Buy New View Book
List Price: US$ 399.99
US$ 380.51

Convert currency

Shipping: FREE
From United Kingdom to U.S.A.

Destination, rates & speeds

Add to Basket

Other Popular Editions of the Same Title

9780306453076: Cancer Neutron Capture Therapy

Featured Edition

ISBN 10:  030645307X ISBN 13:  9780306453076
Publisher: Springer, 1996
Hardcover

Top Search Results from the AbeBooks Marketplace

1.

Published by Springer-Verlag New York Inc., United States (2013)
ISBN 10: 1475795696 ISBN 13: 9781475795691
New Paperback Quantity Available: 10
Print on Demand
Seller:
The Book Depository
(London, United Kingdom)
Rating
[?]

Book Description Springer-Verlag New York Inc., United States, 2013. Paperback. Condition: New. Language: English . Brand New Book ***** Print on Demand *****.There are many human cancers which actively synthesize specific characteristic proteins such as melanomas, thyroid cancer and squamous cell carcinoma. Many cancer researchers have of course tried to utilize this specific activity as a key for the selective treatment of cancers. In the past for example, the molecular hybrid compound of DOPA, a substrate of melanin, and nitrogen mustard N-oxide hydrochloride, a ctyotoxic anti-tumor drug, was synthesized as Melphalan and used to treat malignant melanoma. A major problem arose though in that it was soon found to be highly suppressive toward bone marrow and quite toxic while not being remarkably effective. Thus, malignant melanoma could not be cured by it. Such failure led us to develop a novel bimodal therapeutic system which includes the use of non-toxic potentially cytocidal chemicals which selectively accumulate within the cancer cells and which are converted by a controllable modality into an actively cytocidal element in situ. We can now non-surgically cure malignant melanoma and glioblastoma with our selective cancer treatment, neutron capture therapy (NCT); as can be found in this volume. Included are 124 papers on the latest breaking developments discussed at the Sixth International Symposium on NCT for Cancer held in Kobe during the late autumn of 1994. Softcover reprint of the original 1st ed. 1996. Seller Inventory # AAV9781475795691

More information about this seller | Contact this seller

Buy New
US$ 380.51
Convert currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, rates & speeds

2.

Published by Springer-Verlag New York Inc., United States (2013)
ISBN 10: 1475795696 ISBN 13: 9781475795691
New Paperback Quantity Available: 10
Seller:
Book Depository hard to find
(London, United Kingdom)
Rating
[?]

Book Description Springer-Verlag New York Inc., United States, 2013. Paperback. Condition: New. Language: English . This book usually ship within 10-15 business days and we will endeavor to dispatch orders quicker than this where possible. Brand New Book. There are many human cancers which actively synthesize specific characteristic proteins such as melanomas, thyroid cancer and squamous cell carcinoma. Many cancer researchers have of course tried to utilize this specific activity as a key for the selective treatment of cancers. In the past for example, the molecular hybrid compound of DOPA, a substrate of melanin, and nitrogen mustard N-oxide hydrochloride, a ctyotoxic anti-tumor drug, was synthesized as Melphalan and used to treat malignant melanoma. A major problem arose though in that it was soon found to be highly suppressive toward bone marrow and quite toxic while not being remarkably effective. Thus, malignant melanoma could not be cured by it. Such failure led us to develop a novel bimodal therapeutic system which includes the use of non-toxic potentially cytocidal chemicals which selectively accumulate within the cancer cells and which are converted by a controllable modality into an actively cytocidal element in situ. We can now non-surgically cure malignant melanoma and glioblastoma with our selective cancer treatment, neutron capture therapy (NCT); as can be found in this volume. Included are 124 papers on the latest breaking developments discussed at the Sixth International Symposium on NCT for Cancer held in Kobe during the late autumn of 1994. Softcover reprint of the original 1st ed. 1996. Seller Inventory # LIE9781475795691

More information about this seller | Contact this seller

Buy New
US$ 380.51
Convert currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, rates & speeds

3.

Y. Mishima
Published by Springer (2013)
ISBN 10: 1475795696 ISBN 13: 9781475795691
New Quantity Available: > 20
Print on Demand
Seller:
Books2Anywhere
(Fairford, GLOS, United Kingdom)
Rating
[?]

Book Description Springer, 2013. PAP. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # IQ-9781475795691

More information about this seller | Contact this seller

Buy New
US$ 373.00
Convert currency

Add to Basket

Shipping: US$ 11.77
From United Kingdom to U.S.A.
Destination, rates & speeds

4.

Published by Springer-Verlag New York Inc., United States (2013)
ISBN 10: 1475795696 ISBN 13: 9781475795691
New Paperback Quantity Available: 10
Print on Demand
Seller:
Book Depository International
(London, United Kingdom)
Rating
[?]

Book Description Springer-Verlag New York Inc., United States, 2013. Paperback. Condition: New. Language: English . Brand New Book ***** Print on Demand *****. There are many human cancers which actively synthesize specific characteristic proteins such as melanomas, thyroid cancer and squamous cell carcinoma. Many cancer researchers have of course tried to utilize this specific activity as a key for the selective treatment of cancers. In the past for example, the molecular hybrid compound of DOPA, a substrate of melanin, and nitrogen mustard N-oxide hydrochloride, a ctyotoxic anti-tumor drug, was synthesized as Melphalan and used to treat malignant melanoma. A major problem arose though in that it was soon found to be highly suppressive toward bone marrow and quite toxic while not being remarkably effective. Thus, malignant melanoma could not be cured by it. Such failure led us to develop a novel bimodal therapeutic system which includes the use of non-toxic potentially cytocidal chemicals which selectively accumulate within the cancer cells and which are converted by a controllable modality into an actively cytocidal element in situ. We can now non-surgically cure malignant melanoma and glioblastoma with our selective cancer treatment, neutron capture therapy (NCT); as can be found in this volume. Included are 124 papers on the latest breaking developments discussed at the Sixth International Symposium on NCT for Cancer held in Kobe during the late autumn of 1994. Softcover reprint of the original 1st ed. 1996. Seller Inventory # AAV9781475795691

More information about this seller | Contact this seller

Buy New
US$ 385.16
Convert currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, rates & speeds

5.

Mishima, Y.
Published by Springer (2016)
ISBN 10: 1475795696 ISBN 13: 9781475795691
New Paperback Quantity Available: 1
Print on Demand
Seller:
Ria Christie Collections
(Uxbridge, United Kingdom)
Rating
[?]

Book Description Springer, 2016. Paperback. Condition: New. PRINT ON DEMAND Book; New; Publication Year 2016; Not Signed; Fast Shipping from the UK. No. book. Seller Inventory # ria9781475795691_lsuk

More information about this seller | Contact this seller

Buy New
US$ 380.53
Convert currency

Add to Basket

Shipping: US$ 5.05
From United Kingdom to U.S.A.
Destination, rates & speeds

6.

Mishima, Y.
Published by Springer-Verlag New York Inc. (2013)
ISBN 10: 1475795696 ISBN 13: 9781475795691
New Quantity Available: > 20
Print on Demand
Seller:
Pbshop
(Wood Dale, IL, U.S.A.)
Rating
[?]

Book Description Springer-Verlag New York Inc., 2013. PAP. Condition: New. New Book. Shipped from US within 10 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # IQ-9781475795691

More information about this seller | Contact this seller

Buy New
US$ 386.66
Convert currency

Add to Basket

Shipping: US$ 3.99
Within U.S.A.
Destination, rates & speeds

7.

Y. MISHIMA
Published by Springer (2013)
ISBN 10: 1475795696 ISBN 13: 9781475795691
New Paperback Quantity Available: 1
Seller:
Herb Tandree Philosophy Books
(Stroud, GLOS, United Kingdom)
Rating
[?]

Book Description Springer, 2013. Paperback. Condition: NEW. 9781475795691 This listing is a new book, a title currently in-print which we order directly and immediately from the publisher. For all enquiries, please contact Herb Tandree Philosophy Books directly - customer service is our primary goal. Seller Inventory # HTANDREE0823356

More information about this seller | Contact this seller

Buy New
US$ 414.92
Convert currency

Add to Basket

Shipping: US$ 10.44
From United Kingdom to U.S.A.
Destination, rates & speeds

8.

Published by Springer (2014)
ISBN 10: 1475795696 ISBN 13: 9781475795691
New Softcover Quantity Available: 15
Print on Demand
Seller:
Rating
[?]

Book Description Springer, 2014. Condition: New. This item is printed on demand for shipment within 3 working days. Seller Inventory # LP9781475795691

More information about this seller | Contact this seller

Buy New
US$ 466.70
Convert currency

Add to Basket

Shipping: US$ 3.51
From Germany to U.S.A.
Destination, rates & speeds

9.

Mishima, Y. (Editor)
Published by Springer Verlag (2013)
ISBN 10: 1475795696 ISBN 13: 9781475795691
New Paperback Quantity Available: 2
Seller:
Revaluation Books
(Exeter, United Kingdom)
Rating
[?]

Book Description Springer Verlag, 2013. Paperback. Condition: Brand New. 10.10x7.10 inches. In Stock. Seller Inventory # x-1475795696

More information about this seller | Contact this seller

Buy New
US$ 554.16
Convert currency

Add to Basket

Shipping: US$ 9.81
From United Kingdom to U.S.A.
Destination, rates & speeds